Assessment of In-Vitro Synergy of Fosfomycin with Meropenem, Amikacin and Tigecycline in Whole Genome Sequenced Extended and Pan Drug Resistant Klebsiella Pneumoniae : Exploring A Colistin Sparing Protocol.
Manawr Al-QurainiMeher RizviZaaima Al-JabriHiba SamiMuna Al-MuzahmiZakariya Al-MuharrmiNeelam TanejaIbrahim Al-BusaidiRajeev SomanPublished in: Antibiotics (Basel, Switzerland) (2022)
. FOS with fewer side effects than colistin, excellent tissue distribution and minimal side effects may be recommended in combination with meropenem.